[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649809":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":28,"locations":37,"responsibleParty":53,"collaborators":10,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":58,"sex":64,"minAge":65,"maxAge":10,"enrollmentInfo":66,"targetDuration":10,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"McGill University Health Centre\u002FResearch Institute of the McGill University Health Centre","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Case",null,"Participants with at least one documented ocular adverse effect from a glaucoma medication that resulted in discontinuation of the medication.",[13],"Other: No Interventions",{"label":15,"type":10,"description":16,"interventionNames":17},"Control","Participants without a documented significant ocular adverse effect resulting in medication discontinuation.",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"No Interventions","There is no intervention",[9,15],[24],{"name":25,"affiliation":26,"role":27},"Hady Saheb, MD MPH","MUHC RI","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Ana Hernandez, MD","CONTACT","15149341934","ana.ramirezhernandez@mail.mcgill.ca",{"name":25,"role":31,"phone":35,"phoneExt":10,"email":36},"514-934-1934","hady.saheb@mcgill.ca",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":10,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"McGill University Health Center","RECRUITING","Montreal","Quebec","Canada","CA",{"type":46,"coordinates":47},"Point",[48,49],-73.58781,45.50884,{"lat":49,"lon":48},[52],{"name":30,"role":31,"phone":35,"phoneExt":10,"email":33},{"type":27,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"hady.saheb","Associate Professor of Ophthalmology","100649809","this-study-examines-whether-personality-traits-influence-the-frequency-or-severity-of-ocular-adverse-effects-reported-by-patients-using-glaucoma-medications-the-findings-may-identify-patients-at-greater-risk-of-intolerance-and-support-more-personalized-treatment-and-counselling-100649809",false,"NCT07739784","This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.","Personality Traits and Their Relation to Ocular Adverse Effects From Glaucoma Medications","Adverse Events","Inclusion Criteria:\n\n* Age 18 years or older.\n* Diagnosis of glaucoma.\n* Current or previous treatment with one or more glaucoma medications.\n* Able to provide informed consent.\n* Able to complete the study questionnaires in English or French.\n\nExclusion Criteria:\n\n* Uncontrolled anxiety or depression that was present before glaucoma medication treatment began.\n* Unable to provide informed consent.\n* Unable to complete the study questionnaires in English or French.","ALL","18 Years",{"count":67,"type":68},352,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn whether personality traits are related to eye side effects from glaucoma medications in adults who currently use or previously used these medications.\n\nThe main questions this study aims to answer are:\n\nAre certain personality traits associated with the occurrence or severity of eye side effects from glaucoma medications? Do personality traits differ between people who experience these side effects and those who do not?\n\nParticipants will complete a questionnaire that measures five personality traits: openness, conscientiousness, extraversion, agreeableness, and neuroticism. They will also provide basic demographic information. The researchers will review participants' medical records to collect information about their glaucoma medications and any related eye side effects, including the type and frequency of side effects and whether treatment was changed because of them.\n\nParticipation involves one session lasting approximately 30 minutes. Questionnaires may be completed securely online or in person at the clinic. The study will include approximately 352 adults. No treatment will be assigned or changed as part of this study.",[72],"Glaucoma",[74,75,76],"adverse events","Personality traits","glaucoma","2026-07-30",{"date":79,"type":80},"2026-07-31","ACTUAL",{"date":82,"type":80},"2026-02-25",{"date":84,"type":68},"2027-08-01",{"name":5,"class":6},1]